AlphaQuest LLC Sells 6,895 Shares of GE HealthCare Technologies Inc. $GEHC

AlphaQuest LLC cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 52.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,315 shares of the company’s stock after selling 6,895 shares during the period. AlphaQuest LLC’s holdings in GE HealthCare Technologies were worth $474,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of GEHC. Empowered Funds LLC increased its holdings in GE HealthCare Technologies by 6.1% in the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of GE HealthCare Technologies in the first quarter valued at approximately $259,000. Wealthcare Advisory Partners LLC raised its holdings in GE HealthCare Technologies by 18.6% in the 2nd quarter. Wealthcare Advisory Partners LLC now owns 4,682 shares of the company’s stock valued at $347,000 after buying an additional 733 shares during the last quarter. Valeo Financial Advisors LLC boosted its position in GE HealthCare Technologies by 36.4% during the 2nd quarter. Valeo Financial Advisors LLC now owns 10,363 shares of the company’s stock worth $768,000 after buying an additional 2,766 shares during the period. Finally, KLP Kapitalforvaltning AS grew its holdings in GE HealthCare Technologies by 15.9% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 181,479 shares of the company’s stock worth $13,442,000 after acquiring an additional 24,900 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.4%

NASDAQ GEHC opened at $82.31 on Friday. The stock has a market capitalization of $37.49 billion, a P/E ratio of 18.05, a P/E/G ratio of 2.46 and a beta of 1.08. The business has a 50 day simple moving average of $82.72 and a 200 day simple moving average of $77.50. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

More GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 results and outlook beat — GEHC reported $1.44 EPS (vs. $1.40 est.) and $5.7B revenue (vs. $5.6B est.), and raised FY‑2026 EPS guidance to $4.95–5.15 (above consensus), a key driver of recent optimism. GE HealthCare reports fourth quarter and full year 2025 financial results
• Positive Sentiment: Evercore ISI raised its price target to $98 with an “outperform” rating ( ~19% upside from current levels), signalling continued analyst confidence after the quarter. Benzinga
• Positive Sentiment: Wells Fargo boosted its PT to $97 and kept an “overweight” rating, citing the stronger results/guidance as support for higher estimates. Benzinga
• Positive Sentiment: BTIG raised its price target to $91 and maintained a “buy” call, another vote of confidence from the sell side after the quarter. GE HealthCare (GEHC) PT Raised to $91 at BTIG
• Neutral Sentiment: Market commentary is bullish on further upside — pieces noting the post‑earnings “pop” argue room remains to run, but they largely reflect sentiment rather than new fundamentals. GE HealthCare Technologies Pops, And The Upside Isn’t Over Yet
• Negative Sentiment: Margin pressure noted — several reports highlight a slide in net margin driven by tariffs and product mix, which tempers the EPS beat and could limit multiple expansion. GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
• Negative Sentiment: Coverage notes profit fell despite higher revenue — the WSJ and others emphasize the profitability hit, a reminder that growth is not yet fully translating into margin expansion. GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

Analyst Ratings Changes

A number of brokerages have recently commented on GEHC. Stifel Nicolaus lifted their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday. BTIG Research raised their target price on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Morgan Stanley increased their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday. Finally, Bank of America lifted their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Hold” and a consensus target price of $92.42.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.